Literature DB >> 12884091

Bis-intercalative dinuclear platinum(II) 6-phenyl-2,2'-bipyridine complexes exhibit enhanced DNA affinity but similar cytotoxicity compared to the mononuclear unit.

Hing-Leung Chan1, Dik-Lung Ma, Mengsu Yang, Chi-Ming Che.   

Abstract

The interactions between a series of platinum complexes, including (pyridyl)(6-phenyl-2,2'-bipyridine)platinum(II) hexafluorophosphate (1), three dinuclear bis[(6-phenyl-2,2'-bipyridine)platinum(II)] complexes (2-4), and (4-aminopyridine)(4,6-diphenyl-2,2'-bipyridine)platinum(II) perchlorate (5) with DNA have been investigated. All Pt(II) complexes, except 5, were demonstrated to be DNA intercalators, based on viscosity measurements. Absorption and fluorescence titration results indicated that the addition of a phenyl ring to the 6-phenyl-2,2'-bipyridine ligand dramatically reduced the DNA binding of the Pt(II) complex 5. The dinuclear complexes 2-4 exhibited multiple binding modes of mono/bisintercalation and groove binding, as revealed by viscosity and fluorescence titration measurements. While complexes 2-4 bound to DNA with significantly enhanced affinities as compared to 1, compounds 1 and 2-4 showed similar IC(50) values against a panel of cancer cell lines. In addition, these complexes showed similar cellular uptakes. The results indicated that the cytotoxicity of these (6-phenyl-2,2'-bipyridine)platinum compounds may not be mediated through DNA binding but may involve interacting mechanisms with cellular components other than DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884091     DOI: 10.1007/s00775-003-0477-0

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  22 in total

1.  Syntheses and electronic spectroscopy of [PtL(L')][ClO4] complexes (HL = 6-phenyl-2,2'-bipyridine; L' = pyridine, 4-aminopyridine, 2-aminopyridine, and 2,6-diaminopyridine).

Authors:  J H Yip; J J Vittal
Journal:  Inorg Chem       Date:  2000 Aug, 7       Impact factor: 5.165

Review 2.  Caspases: enemies within.

Authors:  N A Thornberry; Y Lazebnik
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

3.  Ultratight DNA binding of a new bisintercalating anthracycline antibiotic.

Authors:  F Leng; W Priebe; J B Chaires
Journal:  Biochemistry       Date:  1998-02-17       Impact factor: 3.162

4.  Theoretical calculations of the helix-coil transition of DNA in the presence of large, cooperatively binding ligands.

Authors:  J D McGhee
Journal:  Biopolymers       Date:  1976-07       Impact factor: 2.505

5.  Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages.

Authors:  J S Savill; A H Wyllie; J E Henson; M J Walport; P M Henson; C Haslett
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

6.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

7.  Association of anthracycline derivatives with DNA: a fluorescence study.

Authors:  L Valentini; V Nicolella; E Vannini; M Menozzi; S Penco; F Arcamone
Journal:  Farmaco Sci       Date:  1985-06

Review 8.  Apoptosis and programmed cell death in health and disease.

Authors:  I Vermes; C Haanen
Journal:  Adv Clin Chem       Date:  1994       Impact factor: 5.394

9.  Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation.

Authors:  A H Wyllie
Journal:  Nature       Date:  1980-04-10       Impact factor: 49.962

10.  Structure-based design of a new bisintercalating anthracycline antibiotic.

Authors:  J B Chaires; F Leng; T Przewloka; I Fokt; Y H Ling; R Perez-Soler; W Priebe
Journal:  J Med Chem       Date:  1997-01-31       Impact factor: 7.446

View more
  1 in total

1.  Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs.

Authors:  Ying Wang; Jen-Fu Chiu
Journal:  Met Based Drugs       Date:  2008
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.